Metyrapone

CHEMBL934 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
226.3 g/mol
LogP
2.0
Phase
4

This medication blocks an enzyme involved in the production of cortisol in the adrenal glands, helping to lower abnormally high cortisol levels. It is used to diagnose and sometimes treat disorders of adrenal hormone excess.

Berat Molekul

226,2700 g/mol

LogP

2,00

TPSA

42,90 Ų

Lipinski RO5

Lulus

Area Terapeutik

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(C)(C(=O)c1cccnc1)c1cccnc1

InChI

InChI=1S/C14H14N2O/c1-14(2,12-6-4-8-16-10-12)13(17)11-5-3-7-15-9-11/h3-10H,1-2H3

Molecular Formula

C14H14N2O

HBD / HBA

- / 3

Ikatan yang Dapat Dirotasi

3

Atom Berat

17

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

This medication blocks an enzyme involved in the production of cortisol in the adrenal glands, helping to lower abnormally high cortisol levels. It is used to diagnose and sometimes treat disorders of adrenal hormone excess.

Yes, Metyrapone is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL934. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 4174. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.